Lung Cancer

Lung cancer is the leading cause of cancer deaths in the United States. In fact, lung cancer kills more Americans than colon, breast and prostate cancers combined. For men, the average lifetime chance of developing lung cancer is 1 in 13, but for smokers the risk is even higher.

The coordinated care offered by Beaumont’s experts in radiation oncology, medical and surgical oncology, is constantly updated as research reveals new approaches to therapy. This is reflected in the fact that survival rates for lung cancer patients treated at Beaumont Hospitals are higher than the national average.

There are two major types of lung cancer – non-small cell lung cancer and small cell lung cancer. Excellent diagnostic capabilities at Beaumont support timely and accurate diagnoses, so that appropriate treatment can begin quickly. Advanced diagnostic imaging, nearly 100 faculty members, and an accredited radiology residency program make Beaumont one of the busiest hospitals in Michigan for imaging. Since 1995 the freestanding Royal Oak Imaging Center has served outpatients requiring X-ray, CT, MRI, ultrasound or other diagnostic imaging services. In addition, Beaumont Laboratories provide 11 million tests per year.


Lung cancer is the #1 cancer killer in America, claiming more lives than colorectal, breast, pancreatic and prostate cancer combined. Without early detection screening, more than 95 percent of lung cancer patients eventually die from their lung cancer, usually within a few years of when they are diagnosed.

Clinical Trials

Beaumont’s clinical trials are so well respected that the National Cancer Institute (NCI) has designated the hospital as a Community Oncology Research Program. Participation with the Community Oncology Research Program allows eligible patients to enroll in cutting-edge clinical trials without leaving their own community. Ongoing studies research better methods of preventing, diagnosing and treating lung cancer.